These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23790157)
1. Inflammation and the heart - prime time for new therapeutic approaches. Roubille F; Tardif JC Expert Opin Emerg Drugs; 2013 Sep; 18(3):259-61. PubMed ID: 23790157 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory strategies for atherosclerotic artery disease. Agnello F; Capodanno D Expert Opin Drug Saf; 2022 May; 21(5):661-672. PubMed ID: 35094611 [TBL] [Abstract][Full Text] [Related]
8. Lipid pharmacotherapy for treatment of atherosclerosis. Nicholls SJ; Pisaniello AD; Kataoka Y; Puri R Expert Opin Pharmacother; 2014 Jun; 15(8):1119-25. PubMed ID: 24702590 [TBL] [Abstract][Full Text] [Related]
9. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900 [TBL] [Abstract][Full Text] [Related]
10. Novel anti-inflammatory strategies in atherosclerosis. van der Valk FM; van Wijk DF; Stroes ES Curr Opin Lipidol; 2012 Dec; 23(6):532-9. PubMed ID: 23160400 [TBL] [Abstract][Full Text] [Related]
11. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Khan R; Spagnoli V; Tardif JC; L'Allier PL Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Charo IF; Taub R Nat Rev Drug Discov; 2011 May; 10(5):365-76. PubMed ID: 21532566 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for atherosclerosis and atherothrombosis: Past, present and future. Weber C; Badimon L; Mach F; van der Vorst EPC Thromb Haemost; 2017 Jun; 117(7):1258-1264. PubMed ID: 28594053 [TBL] [Abstract][Full Text] [Related]
16. Tackling inflammation in atherosclerosis: Are we there yet and what lies beyond? Bhattacharya P; Kanagasooriyan R; Subramanian M Curr Opin Pharmacol; 2022 Oct; 66():102283. PubMed ID: 36037627 [TBL] [Abstract][Full Text] [Related]
17. Potential of anti-inflammatory agents for treatment of atherosclerosis. Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of drugs targeting inflammation for the management of coronary artery disease. Duchatelle V; Kritikou EA; Tardif JC Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034 [TBL] [Abstract][Full Text] [Related]
19. New anti-inflammatory agents to reduce atherosclerosis. Mach F Arch Physiol Biochem; 2006 Apr; 112(2):130-7. PubMed ID: 16931455 [TBL] [Abstract][Full Text] [Related]
20. Celecoxib for the treatment of atherosclerosis. Papageorgiou N; Zacharia E; Briasoulis A; Charakida M; Tousoulis D Expert Opin Investig Drugs; 2016; 25(5):619-33. PubMed ID: 26940257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]